CorporateHow Glenmark’s AbbVie Deal is a Masterclass in Indian Pharma's R&D AmbitionsBY Vaibhavi Ranjan
MarketsGlenmark Pharma Shares Surge 10% On Arm’s Landmark Deal with AbbVie For Cancer DrugBY Outlook Business Desk
MarketsStocks to Watch: Hindustan Zinc, SpiceJet, Glenmark Pharma and Others in NewsBY Outlook Business Desk
NewsGlenmark Inks Licensing Pact With Jiangsu Alphamab, 3D Medicines For Cancer DrugBY Press Trust of India
